These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4018698)

  • 1. [Antihypertensive action of verapamil. Results with a new delayed-action form for once-daily administration].
    Pozenel H
    Fortschr Med; 1985 Jun; 103(23):639-42. PubMed ID: 4018698
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
    Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
    Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration and antihypertensive effect of slow-release verapamil.
    Schütz E; Ha HR; Bühler FR; Follath F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S346-9. PubMed ID: 6184566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily verapamil in hypertension: intra-arterial recording of blood pressure.
    Brigden GS; Caruana MP; Heber ME; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():48-52. PubMed ID: 3151271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a sustained-release formulation for antihypertensive therapy.
    Skaer TL; Sclar DA; Markowski DJ; Won JK
    J Hum Hypertens; 1993 Oct; 7(5):519-22. PubMed ID: 8263896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs for hypertension--variations on old themes.
    Drug Ther Bull; 1991 Mar; 29(6):21-2. PubMed ID: 1834451
    [No Abstract]   [Full Text] [Related]  

  • 9. [Verapamil 240 mg--effective blood pressure reduction by a single dose?].
    Edmonds D; Baumgart P; Tenschert W; Vetter W; Vetter H
    Schweiz Rundsch Med Prax; 1985 May; 74(19):507-9. PubMed ID: 4012134
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results].
    Guez D; Mallion JM; Degaute JP; Malini PL; Baldwin R; Rodriguez-Pujol D; de Cordoüe A; Barrandon S; Chastang C; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():17-25. PubMed ID: 8952810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
    Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
    Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
    [No Abstract]   [Full Text] [Related]  

  • 12. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
    Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of once-daily verapamil: comparative bioavailability of two sustained-release formulations.
    Muirhead DC; Norris RJ; Cockayne D; Hill GW
    Br J Clin Pract Suppl; 1988 Apr; 60():14-9. PubMed ID: 3151264
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers.
    Fleishaker JC; Sisson TA; Carel BJ; Azie NE
    Clin Pharmacol Ther; 2000 May; 67(5):498-503. PubMed ID: 10824628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and tolerance of combined verapamil retard and hydrochlorothiazide. Results of a double-blind, randomized study].
    von Manteuffel GE; Rakette S; Woll EM; Reinfrank J; Schiemann J
    Fortschr Med; 1995 Sep; 113(26):374-8. PubMed ID: 7498858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard].
    Arabidze GG; Dmitriev VV; Rogoza AN
    Klin Med (Mosk); 1994; 72(5):27-30. PubMed ID: 7853810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
    Hosie J; Dahlöf B; Klein G
    Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
    Antonicelli R; Savonitto S; Tomassini PF; Gambini C; Sardina M; Paciaroni E
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):198-203. PubMed ID: 8032580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.